Carregant...
Selection of β‐Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13‐Year Nationwide Population‐Based Study in Asia
BACKGROUND: It is not clear whether β(1)‐selective or nonselective β‐blockers should be used in patients with cirrhosis and acute myocardial infarction. METHODS AND RESULTS: Medical records were retrieved from Taiwan NHIRD (National Health Insurance Research Database) during 2001‐2013. Patients were...
Guardat en:
| Publicat a: | J Am Heart Assoc |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6404872/ https://ncbi.nlm.nih.gov/pubmed/30371327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008982 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|